Development Level

Tbio 33 | 11,445
Tchem 2 | 1,598
Tclin 1 | 613
Tdark 1 | 6,588

IMPC Phenotype

abnormal behavior 3 | 298
preweaning lethality, complete... 3 | 979
preweaning lethality, incomple... 3 | 499
abnormal cranium morphology 1 | 36
abnormal embryo size 1 | 220
abnormal femur morphology 1 | 14
abnormal retina morphology 1 | 71
abnormal tail movements 1 | 12
decreased body length 1 | 101
decreased circulating serum al... 1 | 82
decreased coping response 1 | 8
decreased fasted circulating g... 1 | 65
decreased grip strength 1 | 116
decreased spleen weight 1 | 10
decreased startle reflex 1 | 75
decreased total body fat amoun... 1 | 207
decreased vertical activity 1 | 208
embryonic lethality prior to o... 1 | 239
embryonic lethality prior to t... 1 | 278
enlarged kidney 1 | 14
increased body weight 1 | 25
increased circulating alkaline... 1 | 122
increased hematocrit 1 | 46
increased hemoglobin content 1 | 45
increased lean body mass 1 | 172
increased neutrophil cell numb... 1 | 46
increased spleen weight 1 | 10
male infertility 1 | 123
microphthalmia 1 | 26
prenatal lethality 1 | 28
short tibia 1 | 97
thrombocytopenia 1 | 56

Disease

Carcinoma 33 | 11,493
atypical teratoid / rhabdoid tumor 21 | 5,112
osteosarcoma 20 | 7,950
ovarian cancer 20 | 8,520
Cancer 19 | 2,499
medulloblastoma, large-cell 19 | 6,241
ependymoma 18 | 4,679
glioblastoma 18 | 5,792
Kidney cancer 17 | 2,613
adult high grade glioma 16 | 3,801
psoriasis 16 | 6,694
lung cancer 14 | 4,740
malignant mesothelioma 14 | 3,232
Astrocytoma, Pilocytic 13 | 3,081
group 4 medulloblastoma 13 | 1,855
lung adenocarcinoma 13 | 2,716
primitive neuroectodermal tumor 12 | 3,035
interstitial cystitis 11 | 2,312
intraductal papillary-mucinous neoplasm (IPMN) 11 | 3,291
Breast cancer 10 | 3,578
group 3 medulloblastoma 10 | 4,104
intraductal papillary-mucinous carcinoma (IPMC) 10 | 2,989
non-small cell lung cancer 10 | 2,890
oligodendroglioma 10 | 2,850
pituitary cancer 10 | 1,972
Alcoholic Intoxication, Chronic 9 | 289
Skin cancer 8 | 469
astrocytic glioma 8 | 2,597
ductal carcinoma in situ 8 | 1,745
invasive ductal carcinoma 8 | 2,951
lung carcinoma 8 | 2,843
pancreatic cancer 8 | 2,398
Melanoma 7 | 711
primary pancreatic ductal adenocarcinoma 7 | 1,109
ulcerative colitis 7 | 1,819
Liver cancer 6 | 604
intraductal papillary-mucinous adenoma (IPMA) 6 | 2,955
pediatric high grade glioma 6 | 1,064
Breast Neoplasms 5 | 445
Cleft lip-palate-ectodermal dysplasia syndrome 5 | 8
cutaneous lupus erythematosus 5 | 1,057
cystic fibrosis 5 | 1,696
tuberculosis 5 | 2,010
Autistic Disorder 4 | 364
Autosomal recessive predisposition 4 | 1,442
Bipolar Disorder 4 | 666
Colorectal Neoplasms 4 | 243
Endometrial cancer 4 | 311
Mammary Neoplasms 4 | 425
Pick disease 4 | 1,894
Rheumatoid arthritis 4 | 1,191
Sparse eyebrow 4 | 42
breast carcinoma 4 | 1,638
colon cancer 4 | 1,478
subependymal giant cell astrocytoma 4 | 2,287
Alopecia 3 | 115
Alzheimer's disease 3 | 658
Autosomal recessive nonsyndromic deafness 89 3 | 6
Cardiomyopathy 3 | 116
Cardiovascular system disease 3 | 246
Cleft Lip 3 | 141
Depressive disorder 3 | 409
Hypotrichosis 3 | 47
Intellectual disability 3 | 1,016
Liver Cirrhosis, Experimental 3 | 769
Multiple Sclerosis 3 | 540
Neoplasm Invasiveness 3 | 161
Nerve Degeneration 3 | 121
Osteoporosis 3 | 363
Palmoplantar keratosis 3 | 74
Prostatic Neoplasms 3 | 495
Sparse eyelashes 3 | 31
Stomach Neoplasms 3 | 300
Syndactyly 3 | 88
Vascular disease 3 | 319
active Crohn's disease 3 | 922
acute quadriplegic myopathy 3 | 1,158
aldosterone-producing adenoma 3 | 665
diabetes mellitus 3 | 1,728
esophageal adenocarcinoma 3 | 737
gastric carcinoma 3 | 807
interstitial lung disease 3 | 298
juvenile dermatomyositis 3 | 1,187
medulloblastoma 3 | 720
pancreatic ductal adenocarcinoma liver metastasis 3 | 1,962
Adenoma 2 | 167
Atherosclerosis 2 | 291
Bladder Neoplasm 2 | 112
Cardiomyopathy, Dilated 2 | 83
Dilated cardiomyopathy 2 | 56
Disease Progression 2 | 136
Globe disease 2 | 67
Heart disease 2 | 306
Kidney disease 2 | 430
Paraplegia 2 | 74
Status Epilepticus 2 | 98
Urinary Bladder Neoplasms 2 | 114
active ulcerative colitis 2 | 764
atypical teratoid/rhabdoid tumor 2 | 357
tuberculosis and treatment for 6 months 2 | 409

Tissue

Endocrine System 37 | 18,159
Male tissues 37 | 17,142
Nervous System 37 | 16,725
Digestive Tract 36 | 17,369
Female tissues 36 | 17,400
Respiratory system 36 | 16,393
Liver and Pancreas 35 | 16,750
Skin and soft tissues 35 | 17,230
Urinary Tract 34 | 16,678
Blood and immune system 33 | 16,909
Cardiovascular System 29 | 15,192

Target Family

Non-IDG 32 | 12,091
Enzyme 3 | 4,145
Kinase 2 | 634

GO Process

adherens junction organization 37 | 37
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Cadherin-18 CDH18 Tdark Non-IDG -0.64897 4.11 125
Cadherin-10 CDH10 Tbio Non-IDG -0.86821 9.34 155
Numb-like protein NUMBL Tbio Non-IDG -2.50313 317.9 171
Cadherin-7 CDH7 Tbio Non-IDG -1.37829 23.4 123
Cadherin-9 CDH9 Tbio Non-IDG -0.94938 8.77 122
Cadherin-24 CDH24 Tbio Non-IDG 0.02 1.02 83
Cadherin-17 CDH17 Tbio Non-IDG -3.38219 2005.5 312
Cadherin-2 CDH2 Tbio Non-IDG -3.19431 1382.9 993
Cadherin-15 CDH15 Tbio Non-IDG -1.56203 34.3 212
Cadherin-12 CDH12 Tbio Non-IDG -1.26700 18.7 205